A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01) - Wikidata - wikimedia - TriplyDB

A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)

A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)

http://www.wikidata.org/entity/Q28344321

about

Taxane-induced arthralgia and myalgia: A literature review.Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.

P2860

Q38711952-CA3EA57F-3FD2-4C3E-BB84-3854C93D91EF Q40700402-EFD7D784-BB0D-486B-B7C9-F9BED65A918A Q46539310-46A20F40-87ED-42BC-8F51-E2798B4605F4

P2860

A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)

http://www.wikidata.org/entity/Q28344321

description

2001 nî lūn-bûn

@nan

2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@ast

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@en

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@nl

type

label

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@ast

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@en

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@nl

prefLabel

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@ast

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@en

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@nl

P1433

Q28344321-37EA9B54-9A74-4AE4-B0A4-2C2B37453AF6

P1476

Q28344321-6B25B0E1-2DFE-4588-8DFC-45327D33AA7A

P2093

Q28344321-181CAB91-69BA-4B1E-9989-263CB9E5D6D1

Q28344321-6E8AB46E-B066-4342-AD28-4C54003272E1

Q28344321-74136A7D-D1D4-4E35-B5A6-D11416AFA08C

Q28344321-8CC7E2EA-0B3B-4E4C-BDC4-8CF5BE3B6BD2

Q28344321-8FCB09F6-AE6A-4CF7-B635-A29135C9ACB5

Q28344321-96D17122-6856-472A-9882-29293B52651C

Q28344321-9C66585E-CCA0-4FA8-B7D8-F3105C87EA8D

Q28344321-A25B6594-FC3A-4B18-A6EB-DE2DFFC9B61E

Q28344321-A4540436-F3E4-4D77-B461-1D1C3DE9A7B4

Q28344321-B30F3132-11D7-4C49-9B6A-1AADD6AC7E98

P2860

Q28344321-173397DC-192D-4318-8B16-57B3A8328799

Q28344321-2CC4A88D-49E5-4A8A-AAB0-7CD4B47F4311

Q28344321-3CD63C8E-1245-4DBB-9366-8163DA8B8630

Q28344321-4FB05F5C-F904-4626-9832-94E8745CA486

Q28344321-5215FF76-D6B4-4026-B096-822D59409464

Q28344321-819ADD97-85FA-4FCF-893F-D7DF3AB9BF81

Q28344321-9DB7DFFF-1FF9-4B6C-8E46-0B8FDECE317A

Q28344321-A82464BF-C19B-4191-A28C-2E85FD7C738E

Q28344321-B860AD6E-82F1-4AB0-949E-61F33CB00AEB

Q28344321-BC940E7C-0751-40CC-AD52-0CA85F99036A

P2888

Q28344321-DE67E243-28B4-479D-8885-F7E051760B24

P304

Q28344321-3022BFB6-2D83-474E-8F17-1559A8EAF827

P31

Q28344321-2DBBF61A-15E3-4604-ADF7-A286C39944EC

P356

Q28344321-F500FFF1-5D23-414D-B49B-99AED3CE8C47

P407

Q28344321-95C8C833-FAB6-44A6-BC08-87FD4A35BC02

P433

Q28344321-A318E2AD-EDF4-46E1-A52E-12864D413944

P478

Q28344321-07EDD338-A925-4125-B8B5-15A251127F56

P50

Q28344321-444D79FF-7D59-48FA-907A-981A4C739D21

P577

Q28344321-6550C5A0-2126-47D9-94B2-3E3C567765E7

P5875

Q28344321-DC593C27-709C-45B5-9378-25CC536BC338

P6179

Q28344321-5DA565A6-5D7D-41EF-BDDD-B9692041DE86

P698

Q28344321-A1B49B5D-5AD9-4A80-9EEE-287E1FF1A4AC

P932

Q28344321-0AAF1717-E9D2-4AB2-98AE-893EF949DA89

P356

P1433

British Journal of Cancer

P1476

A phase II study of sequential ...... cancer (Protocol PV BC 97/01)

@en

P2093

Bernardo G

http://www.w3.org/2001/XMLSchema#string

Brugnatelli S

http://www.w3.org/2001/XMLSchema#string

Danova M

http://www.w3.org/2001/XMLSchema#string

Fava S

http://www.w3.org/2001/XMLSchema#string

Giardina G

http://www.w3.org/2001/XMLSchema#string

Giordano M

http://www.w3.org/2001/XMLSchema#string

Grasso D

http://www.w3.org/2001/XMLSchema#string

Montanari G

http://www.w3.org/2001/XMLSchema#string

Pedrotti C

http://www.w3.org/2001/XMLSchema#string

Poli MA

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II of doxorubicin/taxol in metastatic breast cancer. Argentine Multicenter Taxol Group

Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study

Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study.

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.

The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-resistant breast cancer (Review).

A phase II trial of paclitaxel and epirubicin in advanced breast cancer.

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.

P2888

P304

141-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2001.1897

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Carmine Tinelli

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11881125

http://www.w3.org/2001/XMLSchema#string

P6179

1024766487

http://www.w3.org/2001/XMLSchema#string

P698

11461067

http://www.w3.org/2001/XMLSchema#string

P932

2364040

http://www.w3.org/2001/XMLSchema#string